July 26th 2017, 1 pm. Seminar room 2, TRF
This new Patient Derived Xenograft model using Nod-Scid Gamma immunosuppressed mice is capable of growing cervical carcinoma biopsies taken directly from patients, and for the first time cervical dysplastic tissue. This gives the opportunity to study these tumours over time, and to investigate any changes in their genome.
Supervisors: A/Prof Caroline Gargett, A/Prof Tom Jobling
Panel Chair: Dr Daniel Gough
Independent assessors: Dr Jason Cain, Dr Simon Chu
No comments:
Post a Comment